BTS
GILD icon

BB&T Securities’s Gilead Sciences GILD Stock Holding History

BB&T Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$23.1M Buy
365,818
+110,113
+43% +$7.2M 0.21% 123
2019
Q2 		$17.3M Sell
255,705
-3,144
-1% -$207K 0.16% 175
2019
Q1 		$16.8M Buy
258,849
+27,278
+12% +$1.81M 0.16% 172
2018
Q4 		$14.5M Sell
231,571
-26,241
-10% -$1.83M 0.16% 173
2018
Q3 		$19.9M Sell
257,812
-4,171
-2% -$315K 0.2% 131
2018
Q2 		$18.6M Sell
261,983
-20,117
-7% -$1.42M 0.2% 129
2018
Q1 		$21.3M Buy
282,100
+82,941
+42% +$6.59M 0.24% 106
2017
Q4 		$14.3M Sell
199,159
-54,999
-22% -$4.18M 0.19% 144
2017
Q3 		$20.6M Sell
254,158
-78,588
-24% -$6.01M 0.28% 87
2017
Q2 		$23.6M Sell
332,746
-326,654
-50% -$21.7M 0.34% 67
2017
Q1 		$44.8M Sell
659,400
-65,972
-9% -$4.64M 0.61% 34
2016
Q4 		$57.1M Buy
725,372
+6,580
+0.9% +$489K 0.83% 20
2016
Q3 		$56.9M Buy
718,792
+106,530
+17% +$8.65M 0.85% 19
2016
Q2 		$51.1M Buy
612,262
+250,591
+69% +$22.2M 0.79% 23
2016
Q1 		$33.2M Buy
361,671
+248,987
+221% +$22.5M 0.54% 51
2015
Q4 		$11.4M Buy
112,684
+8,967
+9% +$933K 0.24% 103
2015
Q3 		$10.2M Buy
103,717
+2,002
+2% +$222K 0.22% 98
2015
Q2 		$11.9M Buy
101,715
+3,612
+4% +$395K 0.25% 91
2015
Q1 		$9.63M Buy
98,103
+30,069
+44% +$3.05M 0.21% 100
2014
Q4 		$6.41M Buy
68,034
+30,624
+82% +$3.17M 0.14% 145
2014
Q3 		$3.98M Sell
37,410
-37,302
-50% -$3.65M 0.09% 190
2014
Q2 		$6.19M Buy
74,712
+4,445
+6% +$346K 0.15% 129
2014
Q1 		$4.98M Sell
70,267
-7,107
-9% -$557K 0.13% 136
2013
Q4 		$5.81M Sell
77,374
-6,551
-8% -$456K 0.16% 122
2013
Q3 		$5.28M Buy
83,925
+63,248
+306% +$3.78M 0.16% 112
2013
Q2 		$1.06M Buy
+20,677
New +$1.08M 0.03% 326

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BB&T Securities's GILD Position: Q3 2019 in Review

BB&T Securities increased its Gilead Sciences (GILD) stake by 43% in Q3 2019, buying an estimated $7.2M and bringing the position to 365,818 shares worth $23.1M. The position accounts for 0.21% of the portfolio, ranked #123.

BB&T Securities first reported a position in GILD in Q2 2013 and has held it in 26 quarters since. The position peaked at $57.1M in Q4 2016. 1,464 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • BB&T Securities held 365,818 shares of Gilead Sciences worth $23.1M as of Q3 2019.
  • BB&T Securities bought 110,113 Gilead Sciences shares in Q3 2019, an estimated $7.2M.
  • Gilead Sciences made up 0.21% of BB&T Securities's portfolio in Q3 2019, its #123 holding.
  • BB&T Securities first reported a position in Gilead Sciences in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's Gilead Sciences position peaked at $57.1M in Q4 2016.
  • 1,464 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.